Loading…
Xi'an-based hospital operator running general and specialty hospitals, part of a broader medical investment group.
Xi'an-based hospital operator running general and specialty hospitals, part of a broader medical investment group.
In one line: A Chinese regional hospital-group operator.
Moat: narrow (regulatory licence, scale). Regional hospital-operating licences and facility scale versus smaller clinics.
Headquarters: Xi'an, China · Employees: 8,055
Size Xi'an International Medical Investment (000516.SZ) is a China Health Care company (Hospital/Nursing Management) with a market value of $1.54B, the 1600th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥4.60 on 6 Nov 2026.
Performance Over six months the shares was unchanged, against -5.5% for the median peer and -16.4% for the China market (cap-weighted) — 9th highest of 21 in its peer set.
Growth Revenue fell 1.1% over the last twelve months (peer median +8.7%); the operating margin is -1.6% (peer median 9.9%).
Valuation It trades at 3.2× enterprise value to sales against a peer median of 2.4× (10th most expensive of 21).
Price implies For today's price to make sense, revenue must grow about 14% a year for seven years (Req g). Recent delivered growth is +21%, so the hurdle is -7 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 2.1 points below its cost of capital (7.4% WACC).
Next results Next results expected around 29 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥4.16B | CN¥4.07B | CN¥4.82B | CN¥4.55B | CN¥2.71B |
| Revenue growth | — | -15% | +6% | +68% | — |
| Gross profit | CN¥943M | CN¥167M | CN¥278M | CN¥156M | -CN¥366M |
| EBITDA | n/a | CN¥415M | CN¥545M | CN¥454M | -CN¥264M |
| Net income | -CN¥89.8M | -CN¥313M | -CN¥254M | -CN¥368M | -CN¥1.18B |
| Free cash flow | CN¥1.11B | CN¥1.03B | CN¥463M | CN¥327M | -CN¥703M |
| Capital expenditure | CN¥207M | CN¥262M | CN¥548M | CN¥763M | CN¥1.19B |
| Total debt | CN¥3.94B | CN¥4.21B | CN¥4.64B | CN¥4.74B | CN¥4.46B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g |
|---|---|---|---|---|---|---|
| Xi'an International Medical Investment 000516.SZ | $1.54B | 0% | -1% | -2% | 3.2× | 13.6% |
| Topchoice Medical 600763.SS | $2.51B | -11% | +7% | 26% | 5.7× | 13.6% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 000516.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +5.3% | -0.3% | 6th highest of 21 |
| 6-month return | 0.0% | -5.5% | 9th highest of 21 |
| Distance from 52-week high | -25.7% | -19.7% | 7th lowest of 21 |
| Revenue growth (TTM) | -1.1% | +8.7% | 3rd lowest of 21 |
| Operating margin | -1.6% | 9.9% | 2nd lowest of 20 |
| EV / Sales | 3.2× | 2.4× | 10th most expensive of 21 |
| Growth the price implies (Req g, 7 yrs) | 13.6% | 13.6% | 8th most demanding of 16 |
| Growth delivered (Del g) | +20.6% | +8.7% | 2nd highest of 16 |
| Hurdle (Req g minus delivered) | -7.0 pp | +6.6 pp | 3rd least demanding of 16 |
| ROIC minus cost of capital | -2.1 pp | -1.5 pp | 10th lowest of 20 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Xi'an International Medical Investment 000516.SZ | China | $1.54B | 0% | -1% | -2% | 3.2× | 13.6% | +20.6% |
| Aevis Victoria AEVS.SW | Switzerland | $1.49B | +9% | +15% | -6% | 1.8× | 26.6% | +10.2% |
| Sanbo Hospital Management 301293.SZ | China | $1.48B | -21% | +17% | 6% | 5.4× | n/a | n/a |
| Sienna Senior Living SIA.TO | Canada | $1.63B | -11% | +16% | 10% | 3.2× | 19.6% | +8.6% |
| Spire Healthcare SPI.L | United Kingdom | $1.34B | +68% | +2% | 8% | 1.4× | 9.8% | +11.4% |
| Rainbow Childrens Medicare RAINBOW.NS | India | $1.34B | -4% | +23% | 22% | 6.9× | 30.2% | +21.2% |
| Extendicare EXE.TO | Canada | $1.87B | -9% | +31% | 9% | 1.6× | 11.2% | +8.5% |
| Raffles Medical BSL.SI | Singapore | $1.25B | -15% | -3% | 11% | 1.8× | -2.4% | +6.1% |
| Huaxia Eye Hospital 301267.SZ | China | $1.92B | -16% | +2% | 15% | 2.4× | 3.8% | +10.4% |
| CVS CVSG.L | United Kingdom | $1.23B | +20% | +6% | 11% | 1.7× | 13.7% | +6.9% |
| Park Medi World PARKHOSPS.NS | India | $1.15B | +2% | +21% | n/a | 8.1× | 30.5% | +10.2% |
| Brookdale Senior Living BKD | United States | $2.15B | -31% | -4% | 5% | 2.4× | 22.4% | -1.4% |
| Ramsay Generale de Sante GDS.PA | France | $1.09B | -15% | +3% | 4% | 0.9× | 6.3% | +6.0% |
| Rhon-klinikum RHK.DE | Germany | $1.08B | +14% | +5% | 3% | 0.6× | n/a | n/a |
| Yatharth Hospital and Trauma Care Services YATHARTH.NS | India | $1.05B | +25% | +50% | 16% | 6.8× | n/a | n/a |
| Jupiter Life Line Hospitals JLHL.NS | India | $1,000M | +14% | +17% | 16% | 6.0× | n/a | n/a |
| Ardent Health ARDT | United States | $2.44B | +71% | +3% | 4% | 0.7× | 4.0% | +8.7% |
| Thomson Medical A50.SI | Singapore | $953M | -21% | +6% | 10% | 5.5× | 20.9% | +11.8% |
| HealthCare Global Enterprises HCG.NS | India | $950M | -2% | +14% | 8% | 3.4× | n/a | n/a |
| Topchoice Medical 600763.SS | China | $2.51B | -11% | +7% | 26% | 5.7× | 13.6% | +6.9% |
| Clinica Baviera CBAV.MC | Spain | $940M | -7% | +11% | 20% | 2.5× | 0.7% | +19.7% |